1 Study Coverage
1.1 Typhoid Fever Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Typhoid Fever Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Live Attenuated Vaccine
1.2.3 Conjugate Vaccine
1.2.4 Capsular Polysaccharide Vaccines
1.2.5 Others
1.3 Market by Application
1.3.1 Global Typhoid Fever Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Government Institution
1.3.3 Private Sector
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Typhoid Fever Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Typhoid Fever Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Typhoid Fever Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Typhoid Fever Vaccines Sales by Region
2.4.1 Global Typhoid Fever Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Typhoid Fever Vaccines by Region (2023-2028)
2.5 Global Typhoid Fever Vaccines Revenue by Region
2.5.1 Global Typhoid Fever Vaccines Revenue by Region (2017-2022)
2.5.2 Global Typhoid Fever Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Typhoid Fever Vaccines Sales by Manufacturers
3.1.1 Global Top Typhoid Fever Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Typhoid Fever Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Typhoid Fever Vaccines in 2021
3.2 Global Typhoid Fever Vaccines Revenue by Manufacturers
3.2.1 Global Typhoid Fever Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Typhoid Fever Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Typhoid Fever Vaccines Revenue in 2021
3.3 Global Typhoid Fever Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Typhoid Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Typhoid Fever Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Typhoid Fever Vaccines Sales by Type
4.1.1 Global Typhoid Fever Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Typhoid Fever Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Typhoid Fever Vaccines Revenue by Type
4.2.1 Global Typhoid Fever Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Typhoid Fever Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Typhoid Fever Vaccines Price by Type
4.3.1 Global Typhoid Fever Vaccines Price by Type (2017-2022)
4.3.2 Global Typhoid Fever Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Typhoid Fever Vaccines Sales by Application
5.1.1 Global Typhoid Fever Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Typhoid Fever Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Typhoid Fever Vaccines Revenue by Application
5.2.1 Global Typhoid Fever Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Typhoid Fever Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Typhoid Fever Vaccines Price by Application
5.3.1 Global Typhoid Fever Vaccines Price by Application (2017-2022)
5.3.2 Global Typhoid Fever Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Typhoid Fever Vaccines Market Size by Type
6.1.1 North America Typhoid Fever Vaccines Sales by Type (2017-2028)
6.1.2 North America Typhoid Fever Vaccines Revenue by Type (2017-2028)
6.2 North America Typhoid Fever Vaccines Market Size by Application
6.2.1 North America Typhoid Fever Vaccines Sales by Application (2017-2028)
6.2.2 North America Typhoid Fever Vaccines Revenue by Application (2017-2028)
6.3 North America Typhoid Fever Vaccines Market Size by Country
6.3.1 North America Typhoid Fever Vaccines Sales by Country (2017-2028)
6.3.2 North America Typhoid Fever Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Typhoid Fever Vaccines Market Size by Type
7.1.1 Europe Typhoid Fever Vaccines Sales by Type (2017-2028)
7.1.2 Europe Typhoid Fever Vaccines Revenue by Type (2017-2028)
7.2 Europe Typhoid Fever Vaccines Market Size by Application
7.2.1 Europe Typhoid Fever Vaccines Sales by Application (2017-2028)
7.2.2 Europe Typhoid Fever Vaccines Revenue by Application (2017-2028)
7.3 Europe Typhoid Fever Vaccines Market Size by Country
7.3.1 Europe Typhoid Fever Vaccines Sales by Country (2017-2028)
7.3.2 Europe Typhoid Fever Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Typhoid Fever Vaccines Market Size by Type
8.1.1 Asia Pacific Typhoid Fever Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Typhoid Fever Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Typhoid Fever Vaccines Market Size by Application
8.2.1 Asia Pacific Typhoid Fever Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Typhoid Fever Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Typhoid Fever Vaccines Market Size by Region
8.3.1 Asia Pacific Typhoid Fever Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Typhoid Fever Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Typhoid Fever Vaccines Market Size by Type
9.1.1 Latin America Typhoid Fever Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Typhoid Fever Vaccines Revenue by Type (2017-2028)
9.2 Latin America Typhoid Fever Vaccines Market Size by Application
9.2.1 Latin America Typhoid Fever Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Typhoid Fever Vaccines Revenue by Application (2017-2028)
9.3 Latin America Typhoid Fever Vaccines Market Size by Country
9.3.1 Latin America Typhoid Fever Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Typhoid Fever Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Typhoid Fever Vaccines Market Size by Type
10.1.1 Middle East and Africa Typhoid Fever Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Typhoid Fever Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Typhoid Fever Vaccines Market Size by Application
10.2.1 Middle East and Africa Typhoid Fever Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Typhoid Fever Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Typhoid Fever Vaccines Market Size by Country
10.3.1 Middle East and Africa Typhoid Fever Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Pasteur Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Pasteur Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
11.3 Bharat Biotech
11.3.1 Bharat Biotech Corporation Information
11.3.2 Bharat Biotech Overview
11.3.3 Bharat Biotech Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bharat Biotech Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bharat Biotech Recent Developments
11.4 PaxVax
11.4.1 PaxVax Corporation Information
11.4.2 PaxVax Overview
11.4.3 PaxVax Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 PaxVax Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 PaxVax Recent Developments
11.5 Biomed
11.5.1 Biomed Corporation Information
11.5.2 Biomed Overview
11.5.3 Biomed Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biomed Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biomed Recent Developments
11.6 Prokarium
11.6.1 Prokarium Corporation Information
11.6.2 Prokarium Overview
11.6.3 Prokarium Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Prokarium Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Prokarium Recent Developments
11.7 China National Biotec Group
11.7.1 China National Biotec Group Corporation Information
11.7.2 China National Biotec Group Overview
11.7.3 China National Biotec Group Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 China National Biotec Group Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 China National Biotec Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Typhoid Fever Vaccines Industry Chain Analysis
12.2 Typhoid Fever Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Typhoid Fever Vaccines Production Mode & Process
12.4 Typhoid Fever Vaccines Sales and Marketing
12.4.1 Typhoid Fever Vaccines Sales Channels
12.4.2 Typhoid Fever Vaccines Distributors
12.5 Typhoid Fever Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Typhoid Fever Vaccines Industry Trends
13.2 Typhoid Fever Vaccines Market Drivers
13.3 Typhoid Fever Vaccines Market Challenges
13.4 Typhoid Fever Vaccines Market Restraints
14 Key Findings in The Global Typhoid Fever Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Typhoid Fever Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Live Attenuated Vaccine
Table 3. Major Manufacturers of Conjugate Vaccine
Table 4. Major Manufacturers of Capsular Polysaccharide Vaccines
Table 5. Major Manufacturers of Others
Table 6. Global Typhoid Fever Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Typhoid Fever Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Typhoid Fever Vaccines Sales by Region (2017-2022) & (K Doses)
Table 9. Global Typhoid Fever Vaccines Sales Market Share by Region (2017-2022)
Table 10. Global Typhoid Fever Vaccines Sales by Region (2023-2028) & (K Doses)
Table 11. Global Typhoid Fever Vaccines Sales Market Share by Region (2023-2028)
Table 12. Global Typhoid Fever Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Typhoid Fever Vaccines Revenue Market Share by Region (2017-2022)
Table 14. Global Typhoid Fever Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Typhoid Fever Vaccines Revenue Market Share by Region (2023-2028)
Table 16. Global Typhoid Fever Vaccines Sales by Manufacturers (2017-2022) & (K Doses)
Table 17. Global Typhoid Fever Vaccines Sales Share by Manufacturers (2017-2022)
Table 18. Global Typhoid Fever Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Typhoid Fever Vaccines Revenue Share by Manufacturers (2017-2022)
Table 20. Typhoid Fever Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)
Table 21. Global Typhoid Fever Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Typhoid Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Typhoid Fever Vaccines as of 2021)
Table 23. Typhoid Fever Vaccines Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Typhoid Fever Vaccines Product Offered
Table 25. Date of Manufacturers Enter into Typhoid Fever Vaccines Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)
Table 28. Global Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)
Table 29. Global Typhoid Fever Vaccines Sales Share by Type (2017-2022)
Table 30. Global Typhoid Fever Vaccines Sales Share by Type (2023-2028)
Table 31. Global Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Typhoid Fever Vaccines Revenue Share by Type (2017-2022)
Table 34. Global Typhoid Fever Vaccines Revenue Share by Type (2023-2028)
Table 35. Typhoid Fever Vaccines Price by Type (2017-2022) & (USD/Dose)
Table 36. Global Typhoid Fever Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)
Table 37. Global Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)
Table 38. Global Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)
Table 39. Global Typhoid Fever Vaccines Sales Share by Application (2017-2022)
Table 40. Global Typhoid Fever Vaccines Sales Share by Application (2023-2028)
Table 41. Global Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Typhoid Fever Vaccines Revenue Share by Application (2017-2022)
Table 44. Global Typhoid Fever Vaccines Revenue Share by Application (2023-2028)
Table 45. Typhoid Fever Vaccines Price by Application (2017-2022) & (USD/Dose)
Table 46. Global Typhoid Fever Vaccines Price Forecast by Application (2023-2028) & (USD/Dose)
Table 47. North America Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)
Table 48. North America Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)
Table 49. North America Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)
Table 52. North America Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)
Table 53. North America Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)
Table 56. North America Typhoid Fever Vaccines Sales by Country (2023-2028) & (K Doses)
Table 57. North America Typhoid Fever Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Typhoid Fever Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)
Table 60. Europe Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)
Table 61. Europe Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)
Table 64. Europe Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)
Table 65. Europe Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)
Table 68. Europe Typhoid Fever Vaccines Sales by Country (2023-2028) & (K Doses)
Table 69. Europe Typhoid Fever Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Typhoid Fever Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)
Table 72. Asia Pacific Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)
Table 73. Asia Pacific Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)
Table 76. Asia Pacific Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)
Table 77. Asia Pacific Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Typhoid Fever Vaccines Sales by Region (2017-2022) & (K Doses)
Table 80. Asia Pacific Typhoid Fever Vaccines Sales by Region (2023-2028) & (K Doses)
Table 81. Asia Pacific Typhoid Fever Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Typhoid Fever Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)
Table 84. Latin America Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)
Table 85. Latin America Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)
Table 88. Latin America Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)
Table 89. Latin America Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)
Table 92. Latin America Typhoid Fever Vaccines Sales by Country (2023-2028) & (K Doses)
Table 93. Latin America Typhoid Fever Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Typhoid Fever Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)
Table 96. Middle East and Africa Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)
Table 97. Middle East and Africa Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)
Table 100. Middle East and Africa Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)
Table 101. Middle East and Africa Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)
Table 104. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2023-2028) & (K Doses)
Table 105. Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 107. Sanofi Pasteur Corporation Information
Table 108. Sanofi Pasteur Description and Major Businesses
Table 109. Sanofi Pasteur Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 110. Sanofi Pasteur Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Pasteur Recent Developments
Table 112. GlaxoSmithKline Corporation Information
Table 113. GlaxoSmithKline Description and Major Businesses
Table 114. GlaxoSmithKline Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 115. GlaxoSmithKline Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GlaxoSmithKline Recent Developments
Table 117. Bharat Biotech Corporation Information
Table 118. Bharat Biotech Description and Major Businesses
Table 119. Bharat Biotech Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 120. Bharat Biotech Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bharat Biotech Recent Developments
Table 122. PaxVax Corporation Information
Table 123. PaxVax Description and Major Businesses
Table 124. PaxVax Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 125. PaxVax Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. PaxVax Recent Developments
Table 127. Biomed Corporation Information
Table 128. Biomed Description and Major Businesses
Table 129. Biomed Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 130. Biomed Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Biomed Recent Developments
Table 132. Prokarium Corporation Information
Table 133. Prokarium Description and Major Businesses
Table 134. Prokarium Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 135. Prokarium Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Prokarium Recent Developments
Table 137. China National Biotec Group Corporation Information
Table 138. China National Biotec Group Description and Major Businesses
Table 139. China National Biotec Group Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 140. China National Biotec Group Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. China National Biotec Group Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Typhoid Fever Vaccines Distributors List
Table 145. Typhoid Fever Vaccines Customers List
Table 146. Typhoid Fever Vaccines Market Trends
Table 147. Typhoid Fever Vaccines Market Drivers
Table 148. Typhoid Fever Vaccines Market Challenges
Table 149. Typhoid Fever Vaccines Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Typhoid Fever Vaccines Product Picture
Figure 3. Global Typhoid Fever Vaccines Market Share by Type in 2021 & 2028
Figure 3. Live Attenuated Vaccine Product Picture
Figure 4. Conjugate Vaccine Product Picture
Figure 5. Capsular Polysaccharide Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global Typhoid Fever Vaccines Market Share by Application in 2021 & 2028
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Typhoid Fever Vaccines Report Years Considered
Figure 11. Global Typhoid Fever Vaccines Sales 2017-2028 (K Doses)
Figure 12. Global Typhoid Fever Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Typhoid Fever Vaccines Revenue 2017-2028 (US$ Million)
Figure 14. Global Typhoid Fever Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Typhoid Fever Vaccines Sales Market Share by Region (2017-2022)
Figure 16. Global Typhoid Fever Vaccines Sales Market Share by Region (2023-2028)
Figure 17. North America Typhoid Fever Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 18. North America Typhoid Fever Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Typhoid Fever Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 20. Europe Typhoid Fever Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Typhoid Fever Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 22. Asia-Pacific Typhoid Fever Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Typhoid Fever Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 24. Latin America Typhoid Fever Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Typhoid Fever Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 26. Middle East & Africa Typhoid Fever Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Typhoid Fever Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Typhoid Fever Vaccines in the World: Market Share by Typhoid Fever Vaccines Revenue in 2021
Figure 29. Global Typhoid Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)
Figure 33. Global Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)
Figure 34. North America Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)
Figure 35. North America Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)
Figure 36. North America Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)
Figure 37. North America Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)
Figure 38. North America Typhoid Fever Vaccines Sales Share by Country (2017-2028)
Figure 39. North America Typhoid Fever Vaccines Revenue Share by Country (2017-2028)
Figure 40. U.S. Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)
Figure 43. Europe Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)
Figure 44. Europe Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)
Figure 46. Europe Typhoid Fever Vaccines Sales Share by Country (2017-2028)
Figure 47. Europe Typhoid Fever Vaccines Revenue Share by Country (2017-2028)
Figure 48. Germany Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 49. France Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Typhoid Fever Vaccines Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Typhoid Fever Vaccines Revenue Share by Region (2017-2028)
Figure 59. China Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 62. India Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)
Figure 70. Latin America Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)
Figure 72. Latin America Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Typhoid Fever Vaccines Sales Share by Country (2017-2028)
Figure 74. Latin America Typhoid Fever Vaccines Revenue Share by Country (2017-2028)
Figure 75. Mexico Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Typhoid Fever Vaccines Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Typhoid Fever Vaccines Revenue Share by Country (2017-2028)
Figure 84. Turkey Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)
Figure 87. Typhoid Fever Vaccines Value Chain
Figure 88. Typhoid Fever Vaccines Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
